Aclaris Therapeutics (ACRS) Debt to Equity (2017)
Aclaris Therapeutics (ACRS) has 1 years of Debt to Equity data on record, last reported at $0.0 in Q4 2017.
- For Q4 2017, Debt to Equity changed N/A year-over-year to $0.0; the TTM value through Dec 2017 reached $0.0, changed N/A, while the annual FY2017 figure was $0.0, N/A changed from the prior year.
- Debt to Equity reached $0.0 in Q4 2017 per ACRS's latest filing.
- Across five years, Debt to Equity topped out at $0.0 in Q4 2017 and bottomed at $0.0 in Q4 2017.